Proactive Disclosure

Disclosure of Travel and Hospitality Expenses

Dr. Brien Benoit, Chairperson and CEO

Travel Expenses - December 2, 2006 to March 1, 2007

Date(s)	Purpose	Total Cost
12/4/2006 to 12/5/2006	Hearing in the matter of Janssen-Ortho Inc. and the medicine Concerta	$30.74
12/13/2006 to 11/13/2006	Board Meeting	$15.37
1/17/2007 to 1/17/2007	Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR	$30.74
1/19/2007 to 1/19/2007	Executive Committee Meeting	$15.37
1/22/2007 to 1/23/2007	Conference “Running a Fair Hearing”	$30.74
1/24/2007 to 1/24/2007	Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR	$15.37
1/31/2007 to 1/31/2007	Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR	$15.37
2/5/2007 to 2/5/2007	Hearing in the matter of Teva Neuroscience G.P.-S.E.N.C. and the medicine Copaxone	$45.84
2/22/2007 to 2/22/2007	Hearing in the matter of Eli Lilly Canada Inc. and the medicine Strattera	$15.28
2/26/2007 to 2/26/2007	Health Canada Portfolio Management Meeting	$24.00
2/28/2007 to 2/28/2007	Hearing in the matter of Janssen-Ortho Inc. and the medicine Concerta	$15.28
3/1/2007 to 3/1/2007	Board Meeting	$15.28
	Total:	$269.38

Hospitality Expenses - December 2, 2006 to March 1, 2007

There are no hospitality expenses for this period.